Kamboj Priya, Tyagi Vikas
School of Chemistry and Biochemistry, Thapar institute of engineering and technology (TIET), Patiala, Punjab, India, 147004.
Chembiochem. 2024 Mar 15;25(6):e202300824. doi: 10.1002/cbic.202300824. Epub 2024 Feb 20.
The imidazo[1,2-a]pyridine scaffold has gained significant attention due to its presence as a lead structure in several commercially available pharmaceuticals like zolimidine, zolpidem, olprinone, soraprazan, etc. Further, indole-based imidazo[1,2-a]pyridine derivatives have been found interesting due to their anticancer and antibacterial activities. However, limited methods have been reported for the synthesis of indole-based imidazo[1,2-a]pyridines. In this study, we have successfully developed a biocatalytic process for synthesizing indole-based imidazo[1,2-a]pyridine derivatives using the α-amylase enzyme catalyzed Groebke-Blackburn-Bienayme (GBB) multicomponent reaction of 2-aminopyridine, indole-3-carboxaldehyde, and isocyanide. The generality and robustness of this protocol were shown by synthesizing differently substituted indole-based imidazo[1,2-a]pyridines in good isolated yields. Furthermore, to make α-amylase a reusable catalyst for GBB multicomponent reaction, it was immobilized onto magnetic metal-organic framework (MOF) materials [Fe O @MIL-100(Fe)] and found reusable up to four consecutive catalytic cycles without the significant loss in catalytic activity.
咪唑并[1,2 - a]吡啶骨架因其作为几种市售药物(如佐利米定、唑吡坦、奥普力农、索拉普拉赞等)的先导结构而备受关注。此外,基于吲哚的咪唑并[1,2 - a]吡啶衍生物因其抗癌和抗菌活性而受到关注。然而,报道的用于合成基于吲哚的咪唑并[1,2 - a]吡啶的方法有限。在本研究中,我们成功开发了一种生物催化方法,使用α -淀粉酶催化2 -氨基吡啶、吲哚 - 3 -甲醛和异腈的格罗布克 - 布莱克本 - 比奈梅(GBB)多组分反应来合成基于吲哚的咪唑并[1,2 - a]吡啶衍生物。通过以良好的分离产率合成不同取代的基于吲哚的咪唑并[1,2 - a]吡啶,展示了该方法的通用性和稳健性。此外,为了使α -淀粉酶成为GBB多组分反应的可重复使用催化剂,将其固定在磁性金属有机框架(MOF)材料[Fe₃O₄@MIL - 100(Fe)]上,发现其可连续重复使用四个催化循环而催化活性无显著损失。